A new smart bandage that can heal chronic wounds or battlefield injuries faster than conventional methods has been design by researchers from University of Nebraska-Lincoln, Harvard Medical School and MIT.
The bandage constitutes of electrically conductive fibers coated in a gel that can be individually filled with infection-fighting antibiotics, tissue-regenerating growth factors, painkillers or other medications.
A micro-controller the size of a quarter which can be activated by a smartphone or any other wireless device, releases small amounts of voltage through a selected fiber. That voltage heats the fiber and its hydrogel, releasing whatever cargo it contains.
Each bandage can be equipped with multiple medications meant for a specific or variety of injuries while giving precise control over dosages and delivery schedules. The blend of customization and control could substantially improve or accelerate the healing process.
Dose-dependent Drug Release
Ali Tamayol, assistant professor of mechanical and materials engineering at Nebraska, said:
“This is the first bandage that is capable of dose-dependent drug release. You can release multiple drugs with different release profiles. That’s a big advantage in comparison with other systems. What we did here was come up with a strategy for building a bandage from the bottom up. This is a platform that can be applied to many different areas of biomedical engineering and medicine.”
The team hopes the new bandage will be used to treat chronic skin wounds that stem from diabetes. More than 25 million Americans, and more than 25 percent of U.S. adults 65 and older, could suffer from such wounds. The Centers for Disease Control and Prevention has estimated that diabetes cases will double or triple by the year 2050.
Individuals suffering from combat wounds could also benefit from the bandage’s versatility and customizability, whether to stimulate faster healing of bullet and shrapnel wounds or prevent the onset of infection in remote environments.
“Soldiers on the battlefield may be suffering from a number of different injuries or infections,” Tamayol said. “They might be dealing with a number of different pathogens. Imagine that you have a variable patch that has antidotes or drugs targeted toward specific hazards in the environment.”
Existing bandages range from basic dry patches to more advanced designs that can passively release an embedded medication over time. To evaluate the potential advantages of their smart bandage, Tamayol and his colleagues at Harvard ran a series of experiments.
In one, the researchers applied a smart bandage loaded with growth factor to wounded mice. When compared with a dry bandage, the team’s version regrew three times as much of the blood-rich tissue critical to the healing process.
Another experiment showed that an antibiotic-loaded version of the bandage could eradicate infection-causing bacteria. Collectively, Tamayol said, the experiments also demonstrated that the heat needed to release the medications did not affect their potency.
More Testing Needed
Though the researchers have patented their design, it will need to undergo further animal and then human testing before going to market. That could take several years, though the fact that most of the design’s components are already approved by the Food and Drug Administration should streamline the process.